Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 10, 2012, Pages 1286-1293.e1

  Prajapati, Hasmukh J ^a   Rafi, Shoaib ^a   El Rayes, Bassel F ^a   Kauh, John S ^a   Kooby, David A ^a   Kim, Hyun S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adverse event; AE; Barcelona Clinic Liver Cancer; BCLC; Cancer of the Italian Liver Program; CLIP; DEB; drug eluting bead; Eastern Cooperative Oncology Group; ECOG; HCC; hepatocellular carcinoma; National Cancer Institute Common Terminology Criteria for Adverse Events; NCI CTCAE; performance status; PES; portal vein thrombosis; postembolization syndrome; PS; PVT; SD; standard deviation; TAE; transarterial embolization

Indexed keywords

CEFAZOLIN; CIPROFLOXACIN; DIPHENHYDRAMINE; DOCUSATE SODIUM; DOXORUBICIN; FENTANYL CITRATE; LEVOFLOXACIN; METRONIDAZOLE; MIDAZOLAM; ONDANSETRON; OXYCODONE; PROMETHAZINE;

ADULT; AGED; ARTICLE; CANCER STAGING; CATHETER; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; DRUG ELUTING BEAD; FEMALE; HOSPITALIZATION; HUMAN; INFECTION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT SAFETY; PRIORITY JOURNAL; VOMITING;

EID: 84866707150     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.07.003     Document Type: Article

References (29)

1. J.M. Llovet, J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 2003 429 442
2. J.M. Llovet, M.I. Real, X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
3. S.J. Wigmore Postchemoembolisation syndrome - tumour necrosis or hepatocyte injury? Br J Cancer 2003 1423 1427
4. B.C. Wible, W.S. Rilling, P. Drescher Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization J Vasc Interv Radiol 21 2010 1024 1030
5. D.A. Kooby, V. Egnatashvili, S. Srinivasan Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma J Vasc Interv Radiol 21 2010 224 230
6. G. Pietrosi, R. Miraglia, A. Luca Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis J Vasc Interv Radiol 20 2009 896 902
7. R. Sacco, I. Bargellini, M. Bertini Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma J Vasc Interv Radiol 22 2011 1545 1552
8. J. Lammer, K. Malagari, T. Vogl Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 2010 41 52
9. K. Malagari, K. Chatzimichael, E. Alexopoulou Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients Cardiovasc Intervent Radiol 31 2008 269 280
10. M.E. Charlson, P. Pompei, K.L. Ales, C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
11. National Cancer Institute Common terminology criteria for adverse events (CTCAE) version 4, 2009 http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14- QuickReference-5x7.pdf Accessed February 22, 2012
12. W.H. Hall, R. Ramachandran, S. Narayan, A.B. Jani, S. Vijayakumar An electronic application for rapidly calculating Charlson comorbidity score BMC Cancer 4 2004 94
13. S.F. Altekruse, K.A. McGlynn, M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
14. H. Hung Treatment modalities for hepatocellular carcinoma Curr Cancer Drug Targets 5 2005 131 138
15. D.B. Brown, J.F. Geschwind, M.C. Soulen, S.F. Millward, D. Sacks Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies J Vasc Interv Radiol 20 2009 S317 S323
16. H.T. Hu, J.H. Kim, L.S. Lee Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort J Vasc Interv Radiol 22 2011 917 923
17. K. Malagari, M. Pomoni, A. Kelekis Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma Cardiovasc Intervent Radiol 33 2010 541 551
18. M. Varela, M.I. Real, M. Burrel Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol 46 2007 474 481
19. A.L. Lewis, R.R. Taylor, B. Hall, M.V. Gonzalez, S.L. Willis, P.W. Stratford Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization J Vasc Interv Radiol 17 2006 1335 1343
20. K. Hong, A. Khwaja, E. Liapi, M.S. Torbenson, C.S. Georgiades, J.F. Geschwind New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer Clin Cancer Res 12 2006 2563 2567
21. A.L. Lewis, M.V. Gonzalez, S.W. Leppard Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution J Mater Sci Mater Med 18 2007 1691 1699
22. A.L. Lewis, M.V. Gonzalez, A.W. Lloyd DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization J Vasc Interv Radiol 17 2006 335 342
23. R.T. Poon, W.K. Tso, R.W. Pang A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead Clin Gastroenterol Hepatol 5 2007 1100 1108
24. R. Dhanasekaran, D.A. Kooby, C.A. Staley, J.S. Kauh, V. Khanna, H.S. Kim Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC) J Surg Oncol 101 2010 476 480
25. G. Pelletier, A. Roche, O. Ink A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 1990 181 184
26. N. Kothary, J.L. Weintraub, J. Susman, J.H. Rundback Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk J Vasc Interv Radiol 18 2007 1517 1526 quiz 1527
27. L. Marelli, R. Stigliano, C. Triantos Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25
28. J.W. Mitchell, W.G. O'Connell, P. Kisza Safety and feasibility of outpatient transcatheter hepatic arterial embolization for hepatocellular carcinoma J Vasc Interv Radiol 20 2009 203 208
29. Y. Kondo, H. Yoshida, R. Tateishi Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma J Gastroenterol Hepatol 22 2007 197 203